These include cutting-edge peptide therapies and metabolic compounds that tackle weight loss from different angles than GLP-1 drugs like Ozempic
Nutrients, 14(24), 5196
For those comfortable with this risk-benefit profile, Epithalon offers a unique approach to cellular rejuvenation unavailable through any other peptide class or pharmaceutical intervention
The compound has been evaluated in multiple randomised, placebo-controlled trials and has generated results that have been published in leading peer-reviewed journals including the New England Journal of Medicine, The Lancet, and Nature Medicine
It does, however, limit the ability of patients and referring clinicians to evaluate the clinical standards governing formulation decisions
Upon oxidative stress, sudden MPT causes massive ion influx that dissipates mitochondrial membrane potential and shuts down OXPHOS, ATP production and ROS overgeneration